Ο ρόλος της αλυσίδας αξίας στη διαχείρηση της εφοδιαστικής αλυσίδας των φαρμακοβιομηχανιών
View/
Keywords
Εφοδιαστική αλυσίδα ; ΦαρμακοβιομηχανίαAbstract
Τhe pharmaceutical market is undoubtedly one of the most special and complex industries in the industry that has a strong interest throughout the value chain. In 2016, it was a turning point for the pharmaceutical industry as it made significant changes in how consumers and regulators were approached in the pharmaceutical sector, leading some trends to push major pharmaceutical companies to a turning point. Larger consumer expectations, increased control by regulators and the unceasing slowdown in mergers and acquisitions have signaled that there is more pressure than ever on the reorganization of the food industry.
It seems that the supply chain management sector of recent years has become very important as more and more businesses have begun to grasp the importance of becoming a competitive business. In order to develop better practices, in 2017 it found organizations using a range of new solutions to "activate" their supplies, making them able to predict results and implement actions. Like other companies that rely heavily on technology development, large data, and engineering learning, there is a strong prediction for return on investment in bidding systems - something that pharmaceutical companies will start experimenting with seriously. In 2018 these developments will continue to evolve to make the supply chain independent.
The paper examines the case study of the Greek pharmaceutical company FAMAR.
Postgraduate Studies Programme
Βιομηχανική Διοίκηση και ΤεχνολογίαDepartment
Σχολή Ναυτιλίας και Βιομηχανίας. Tμήμα Βιομηχανικής Διοίκησης και TεχνολογίαςNumber of pages
85Language
GreekCollections
Except where otherwise noted, this item's license is described as
Attribution-NonCommercial-NoDerivatives 4.0 Διεθνές
Attribution-NonCommercial-NoDerivatives 4.0 Διεθνές